Cargando…
Efficacy of SXN in the Treatment of Iron Deficiency Anemia: A Phase IV Clinical Trial
Shengxuening (SXN) tablet is extracted from the excrement of the silkworm and has effects on hematopoiesis. The main components of SXN are chlorophyll derivatives and sodium iron chlorophyllin (SIC). The present study aims to investigate the efficiency and safety of SXN on iron deficiency anemia. Th...
Autores principales: | Ding, Lu, Xu, Lulin, Jin, Yanxia, Wei, Yongchang, Pan, Yunbao, Sattar, Safat, Tan, Yuxin, Yang, Tian, Zhou, Fuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421013/ https://www.ncbi.nlm.nih.gov/pubmed/30941201 http://dx.doi.org/10.1155/2019/8796234 |
Ejemplares similares
-
MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5
por: Wu, Balu, et al.
Publicado: (2019) -
miR-15b-5p Promotes Growth and Metastasis in Breast Cancer by Targeting HPSE2
por: Wu, Balu, et al.
Publicado: (2020) -
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017) -
Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
por: Naqash, Amreen, et al.
Publicado: (2018) -
Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia
previously unresponsive to or unable to tolerate oral iron
por: Vadhan-Raj, Saroj, et al.
Publicado: (2014)